B CELL MALIGNANCIES
Clinical trials for B CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer drug zanubrutinib tested for Long-Term safety in 955 patients
Disease control OngoingThis study looks at the long-term safety of the drug zanubrutinib in people with B-cell cancers who were already in a related trial. About 955 participants will continue or start taking zanubrutinib. The main goal is to track side effects and see how well the drug controls the ca…
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE3 • Sponsor: BeiGene • Aim: Disease control
Last updated May 26, 2026 07:48 UTC
-
Bridge study offers ongoing access to promising cancer drug for stable patients
Disease control OngoingThis study gives continued access to the drug parsaclisib (alone or with other medicines) for people with B-cell cancers who were already taking it in an earlier Incyte-sponsored trial and were seeing benefit. About 112 participants who have at least stable disease and are tolera…
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New pill for blood cancers enters first human tests
Disease control OngoingThis early-phase study tests a new drug called ABBV-525 in people with B-cell cancers like lymphoma and leukemia. The goal is to check safety and find the best dose. About 78 adults will take the drug by mouth at different dose levels over up to 64 months.
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated May 20, 2026 11:56 UTC